Compound ID | 1690
Class: Type I signal peptidase inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Broad spectrum antibacterial activity against Gram-negative bacteria |
| Institute where first reported: | Department of Infectious Diseases, San Francisco, USA |
| Year first mentioned: | 2018 |
| Highest development stage: | Preclinical |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/134827876 |
| Guide to Pharmacology: | G0775 |
| Citation: | https://www.nature.com/articles/s41586-018-0483-6 |